Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-11, Stock:JNJ, The news for the past five days is as follows:
2019-09-04: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Health Care Sector Update for 09/04/2019: OPGN, PBYI, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 09/04/2019: OPGN, PBYI, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Forget Coca-Cola: Here Are 2 Better Dividend Stocks.
2019-09-05: NEWS1: How Will Johnson & Johnson&apos;s Opioid Case Ruling Impact Big Pharma Stocks?.NEWS2: Mallinckrodt’s plunges toward record low after report bankruptcy is being considered.NEWS3: Mallinckrodt’s stock suffers record plunge after report bankruptcy is being considered.NEWS4: Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?.NEWS5: Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?.NEWS6: J&J's Stelara Gets Approval in EU for Ulcerative Colitis.NEWS7: J&J's Stelara Gets Approval in EU for Ulcerative Colitis.NEWS8: 4 Classic Defensive Dividend Stocks for Steady Returns.NEWS9: 4 Classic Defensive Dividend Stocks for Steady Returns.NEWS10: Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease.NEWS11: J&J's Stelara Gets Approval in EU for Ulcerative Colitis.NEWS12: Health Care Sector Update for 09/05/2019: MNK, ZFGN, LVGO, JNJ, PFE, MRK, ABT, AMGN.NEWS13: Health Care Sector Update for 09/05/2019: MNK, ZFGN, LVGO, JNJ, PFE, MRK, ABT, AMGN.NEWS14: [video]Johnson & Johnson Is Especially Attractive in Today's Low-Rate Environment.NEWS15: Johnson & Johnson Is A Massive Pharma Stock — But Should You Buy It?.NEWS16: 4 Defensive Dividend Stocks for Steady Returns.NEWS17: [video]Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy.NEWS18: How Important Is Keytruda For Merck?.NEWS19: How Important Is Keytruda For Merck?.NEWS20: Can Biosimilars Be The Next Growth Driver For Pfizer?.NEWS21: Can Biosimilars Be The Next Growth Driver For Pfizer?.NEWS22: J&J: The next target of anger over America’s opioid crisis?.NEWS23: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS24: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS25: Large U.S. Stocks May Be Underestimating The Worldwide Manufacturing Recession.NEWS26: Large U.S. Stocks May Be Underestimating The Worldwide Manufacturing Recession.
2019-09-06: NEWS1: Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs.NEWS2: Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Mallinckrodt’s suffers record plunge after report bankruptcy is being considered.NEWS5: Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation.NEWS6: How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?.NEWS7: How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?.
2019-09-09: NEWS1: Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties.NEWS2: The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers.NEWS3: Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK.NEWS4: Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK.NEWS5: An Intrinsic Calculation For Johnson & Johnson (NYSE:JNJ) Suggests It's 43% Undervalued.NEWS6: Here's Why Teva Pharmaceuticals Dropped 13% in August.NEWS7: Here's Why Teva Pharmaceuticals Dropped 13% in August.NEWS8: Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August.NEWS9: Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August.
2019-09-10: NEWS1: The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers.NEWS2: The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers.NEWS3: Theravance Announces Positive Early Data on JAK Inhibitor.NEWS4: 10 Healthcare Stocks to Buy Despite the Headlines.NEWS5: Health Care Sector Update for 09/10/2019: CANF, MNK, MESO, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Health Care Sector Update for 09/10/2019: CANF, MNK, MESO, JNJ, PFE, MRK, ABT, AMGN.NEWS7: What To Make of Roche's Drugs With $21 Billion In Sales Nearing Patent Expiry?.NEWS8: What To Make of Roche's Drugs With $21 Billion In Sales Nearing Patent Expiry?.NEWS9: Bristol-Myers Squibb's Revenues: How Does Bristol-Myers Squibb Make Money?.NEWS10: Bristol-Myers Squibb's Revenues: How Does Bristol-Myers Squibb Make Money?.

Answer: Rise